R01 CA254938/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	3
2023	1
2024	0

Page 1

A potent tumor-selective ERK pathway inactivator with high therapeutic index.

Zuo Z, Liu J, Sun Z, Silverstein R, Zou M, Finkel T, Bugge TH, Leppla SH, Liu S. Zuo Z, et al. PNAS Nexus. 2022 Jul 1;1(3):pgac104. doi: 10.1093/pnasnexus/pgac104. eCollection 2022 Jul. PNAS Nexus. 2022. PMID: 35899070 Free PMC article.

ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth.

Zuo Z, Liu J, Sun Z, Cheng YW, Ewing M, Bugge TH, Finkel T, Leppla SH, Liu S. Zuo Z, et al. Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2211927120. doi: 10.1073/pnas.2211927120. Epub 2022 Dec 27. Proc Natl Acad Sci U S A. 2023. PMID: 36574698 Free PMC article.

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.

Duru N, Pawar NR, Martin EW, Buzza MS, Conway GD, Lapidus RG, Liu S, Reader J, Rao GG, Roque DM, Leppla SH, Antalis TM. Duru N, et al. Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2201423119. doi: 10.1073/pnas.2201423119. Epub 2022 Jul 8. Proc Natl Acad Sci U S A. 2022. PMID: 35867758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year